DMAC DiaMedica Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 10, 2026
$8.23
· of 52w range
· above low
· to high
$5.2552w low
$10.2052w high
Market Cap (MRQ)
$444M
your badges
52W Range
$5–$10
Analyst Rating
BUY
Price Target
$16
P/E
·
ROE
-78.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
DMAC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.23
Market Cap (MRQ)
$444M
ROE
-78.7%
52W Range
$5–$10
DMAC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Nov. 15, 2018 | 1-for-20 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2018-12-31 → 2018-12-31
Free Cash Flow$-29M2018-12-31 → 2025-12-31
Net margin·2018-12-31 → 2018-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | DMAC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 11.65Y avg ≈3.8 | ≈3.8 | 2.7 | Overvalued | |
| Price / FCF (TTM) | -14.15Y avg ≈-8.5 | ≈-8.5 | · | · | |
| Price / Cash Flow (TTM) | -14.15Y avg ≈-8.5 | ≈-8.5 | · | · | |
| Price / Tangible Book | 7.95Y avg ≈3.8 | ≈3.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | DMAC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -60.8%5Y avg ≈-44.9% | ≈-44.9% | -39.0% | Weak | |
| ROE | -78.7%5Y avg ≈-48.2% | ≈-48.2% | -52.6% | Weak | |
| ROIC | -61.4%5Y avg ≈-48.8% | ≈-48.8% | -34.0% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | DMAC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 6.75Y avg ≈17.0 | ≈17.0 | 7.9 | In line | |
| Quick Ratio (MRQ) | 6.65Y avg ≈16.9 | ≈16.9 | 1.7 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
2.3%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.19 | $-0.20 | 6.9% |
| March 31, 2026 | May 11, 2026 | $-0.19 | $-0.19 | -0.69% |
| Dec. 31, 2025 | $-0.17 | $-0.18 | 7.4% | |
| Sept. 30, 2025 | $-0.17 | $-0.16 | -4.2% | |
| June 30, 2025 | $-0.18 | $-0.19 | 7.1% | |
| March 31, 2025 | $-0.18 | $-0.18 | 2.0% | |
| Dec. 31, 2024 | $-0.18 | $-0.18 | -2.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $500.0K | |
| R&D Expense | $25M | $19M | $13M | $8M | $9M | $8M | $8M | $5M | |
| SG&A Expense | $10M | $8M | $8M | $6M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $34M | $27M | $21M | $14M | $14M | $13M | $12M | $7M | |
| Operating Income | $-34M | $-27M | $-21M | $-14M | $-14M | $-13M | $-12M | $-7M | |
| Interest Income | $2M | $2M | $2M | · | · | · | · | · | |
| Other Non-op | $2M | $2M | $2M | $353.0K | $82.0K | $229.0K | $119.0K | $-68.0K | |
| Pretax Income | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| Income Tax | $28.0K | $30.0K | $43.0K | $28.0K | $28.0K | $27.0K | $31.0K | $80.0K | |
| Net Income | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| EPS (Basic) | $-0.70 | $-0.60 | $-0.60 | $-0.52 | $-0.65 | · | · | · | |
| Shares (Basic) | 46,980,777 | 40,404,681 | 32,566,723 | 26,443,067 | 20,773,399 | · | · | · | |
| EBITDA | $-34M | $-27M | $-21M | $-14M | $-14M | · | $-12M | $-7M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $3M | $5M | $5M | $5M | $7M | $4M | $17M | |
| Short-term Investments | $44M | $41M | $48M | $29M | $40M | $20M | $4M | · | |
| Receivables | $258.0K | $236.0K | $369.0K | $82.0K | $130.0K | $340.0K | $823.0K | $780.0K | |
| Prepaid Expense | $481.0K | $227.0K | $411.0K | $251.0K | $197.0K | $64.0K | $47.0K | $369.0K | |
| Current Assets | $61M | $45M | $54M | $34M | $45M | $28M | $9M | $18M | |
| PP&E (Net) | $145.0K | $148.0K | $131.0K | $136.0K | $70.0K | $74.0K | $64.0K | $96.0K | |
| PP&E (Gross) | $295.0K | $262.0K | $231.0K | $216.0K | $137.0K | $131.0K | $107.0K | $120.0K | |
| Accum. Depreciation | $150.0K | $114.0K | $100.0K | $80.0K | $67.0K | $57.0K | $43.0K | $24.0K | |
| Total Assets | $61M | $46M | $54M | $34M | $46M | $28M | $9M | $18M | |
| Accounts Payable | $1M | $940.0K | $926.0K | $734.0K | $509.0K | $1M | $182.0K | $483.0K | |
| Accrued Liabilities | $4M | $4M | $2M | $1M | $966.0K | $864.0K | $1M | $808.0K | |
| Current Liabilities | $5M | $5M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Capital Leases | $124.0K | $225.0K | $316.0K | $396.0K | $3.0K | $46.0K | $105.0K | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Paid-in Capital | $229M | $181M | $167M | $128M | $127M | $95M | $64M | $63M | |
| Retained Earnings | $-173M | $-140M | $-116M | $-96M | $-83M | $-69M | $-57M | $-46M | |
| AOCI | $50.0K | $23.0K | $6.0K | $-74.0K | $-51.0K | $-2.0K | $2.0K | · | |
| Stockholders' Equity | $56M | $41M | $51M | $32M | $44M | $26M | $8M | $17M | |
| Liabilities + Equity | $61M | $46M | $54M | $34M | $46M | $28M | $9M | $18M | |
| Shares Outstanding | 53,742,370 | 42,818,660 | 37,958,000 | 26,443,067 | 26,443,067 | 18,746,157 | 12,006,874 | 11,956,874 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $2M | $2M | $2M | $2M | $2M | $1M | $620.0K | |
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $-29M | $-22M | $-19M | $-12M | $-12M | $-9M | $-9M | $-6M | |
| CapEx | $40.0K | $25.0K | $24.0K | $81.0K | $22.0K | $47.0K | $2.0K | $50.0K | |
| Investing Cash Flow | $-2M | $9M | $-18M | $12M | $-21M | $-16M | $-4M | $-50.0K | |
| Stock Issued | $43M | $12M | $37M | $0 | $30M | $29M | · | $15M | |
| Net Stock Activity | $43M | $12M | $37M | $0 | $30M | · | · | $15M | |
| Financing Cash Flow | $44M | $12M | $37M | $-6.0K | $30M | $29M | $70.0K | $21M | |
| Net Change in Cash | $13M | $-2M | $-185.0K | $21.0K | $-3M | $4M | $-13M | $15M | |
| Free Cash Flow | $-29M | $-22M | $-19M | $-12M | $-12M | · | $-9M | $-6M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -1352.2% | |
| Net Margin | · | · | · | · | · | · | · | -1146.8% | |
| Pretax Margin | · | · | · | · | · | · | · | -1130.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | -1352.2% | |
| ROA | -60.8% | -48.6% | -43.8% | -34.2% | -36.9% | · | -77.8% | -56.9% | |
| ROE | -78.7% | -55.1% | -36.3% | -40.9% | -29.8% | · | -123.0% | -54.3% | |
| ROIC | -61.4% | -65.6% | -41.8% | -44.1% | -31.1% | · | -152.6% | -40.3% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | 8.3 | 19.3 | 15.6 | 29.8 | · | 6.7 | 13.9 | |
| Quick Ratio | 11.7 | 8.2 | 19.1 | 15.5 | 29.7 | · | 6.6 | 13.6 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | 1.2 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.04 | $0.95 | $1.35 | $1.20 | $1.66 | · | $0.63 | $1.42 | |
| Cash / Share | $0.29 | $0.07 | $0.12 | $0.18 | $0.18 | · | $0.32 | $1.41 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $500.0K | |
| Net Income TTM | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| Market Cap | $428M | $233M | $108M | $42M | $99M | · | $58M | $35M | |
| P/S | · | · | · | · | · | · | · | 69.6 | |
| P/B | 7.6 | 5.7 | 2.1 | 1.3 | 2.2 | · | 7.6 | 2.0 | |
| P / Tangible Book | 7.6 | 5.7 | 2.1 | 1.3 | 2.2 | 7.3 | · | · | |
| P / Cash Flow | -14.7 | -10.5 | -5.8 | -3.6 | -8.1 | · | -6.4 | -6.1 | |
| P / FCF | -14.7 | -10.5 | -5.7 | -3.6 | -8.0 | · | -6.4 | -6.1 |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $8M | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | $3M | $3M | $4M | $2M | $2M | |
| SG&A Expense | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | |
| Operating Income | $-10M | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-7M | $-6M | $-6M | $-6M | $-5M | $-5M | $-6M | $-4M | $-3M | |
| Interest Income | · | $470.0K | $472.0K | $440.0K | $313.0K | $444.0K | $543.0K | $618.0K | $524.0K | $616.0K | · | · | · | · | · | · | |
| Other Non-op | $366.0K | $447.0K | $1M | $-21.0K | $314.0K | $443.0K | $2M | $-2.0K | $2.0K | $597.0K | $709.0K | $693.0K | $271.0K | $256.0K | $229.0K | $76.0K | |
| Pretax Income | $-10M | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-5M | $-4M | $-3M | |
| Income Tax | $7.0K | $7.0K | $10.0K | $6.0K | $6.0K | $6.0K | $9.0K | $7.0K | $7.0K | $7.0K | $22.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | |
| Net Income | $-10M | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-5M | $-4M | $-3M | |
| EPS (Basic) | $-0.19 | $-0.19 | $-0.17 | $-0.17 | $-0.18 | $-0.18 | $-0.18 | $-0.15 | $-0.13 | $-0.14 | $-0.12 | $-0.12 | $-0.16 | $-0.20 | $-0.14 | $-0.12 | |
| Shares (Basic) | 53,894,295 | 53,793,490 | · | 49,630,119 | 42,957,619 | 42,843,938 | · | 42,751,577 | 38,068,378 | 37,958,000 | · | 37,949,422 | 27,312,008 | 26,448,941 | · | 26,443,067 | |
| EBITDA | $-10M | $-10M | · | $-9M | $-8M | $-8M | · | $-7M | $-6M | $-6M | · | $-5M | $-5M | $-6M | · | $-3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $5M | $16M | $3M | $4M | $3M | $3M | $4M | $14M | $2M | $5M | $2M | $6M | $2M | $5M | $3M | |
| Short-term Investments | $38M | $46M | $44M | $52M | $26M | $34M | $41M | $46M | $40M | $44M | $48M | $44M | $35M | $27M | $29M | $33M | |
| Receivables | $244.0K | $301.0K | $258.0K | $260.0K | $161.0K | $253.0K | $236.0K | $290.0K | $391.0K | $399.0K | $369.0K | $310.0K | $188.0K | $57.0K | $82.0K | $75.0K | |
| Prepaid Expense | $567.0K | $731.0K | $481.0K | $445.0K | $680.0K | $649.0K | $227.0K | $280.0K | $568.0K | $569.0K | $411.0K | $1M | $675.0K | $962.0K | $251.0K | $322.0K | |
| Current Assets | $44M | $52M | $61M | $56M | $31M | $37M | $45M | $51M | $55M | $47M | $54M | $48M | $41M | $30M | $34M | $36M | |
| PP&E (Net) | $133.0K | $142.0K | $145.0K | $150.0K | $152.0K | $149.0K | $148.0K | $151.0K | $152.0K | $132.0K | $131.0K | $135.0K | $133.0K | $136.0K | $136.0K | $110.0K | |
| PP&E (Gross) | $297.0K | $301.0K | $295.0K | $289.0K | $280.0K | $271.0K | $262.0K | $254.0K | $250.0K | $238.0K | $231.0K | $232.0K | $222.0K | $219.0K | $216.0K | $183.0K | |
| Accum. Depreciation | $164.0K | $159.0K | $150.0K | $139.0K | $128.0K | $122.0K | $114.0K | $103.0K | $98.0K | $106.0K | $100.0K | $97.0K | $89.0K | $83.0K | $80.0K | $73.0K | |
| Total Assets | $45M | $53M | $61M | $57M | $31M | $39M | $46M | $53M | $57M | $49M | $54M | $58M | $62M | $30M | $34M | $37M | |
| Accounts Payable | $3M | $3M | $1M | $2M | $1M | $2M | $940.0K | $1M | $759.0K | $716.0K | $926.0K | $863.0K | $856.0K | $2M | $734.0K | $864.0K | |
| Accrued Liabilities | $4M | $2M | $4M | $3M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $1M | $1M | $956.0K | $1M | $637.0K | |
| Current Liabilities | $7M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | |
| Capital Leases | $69.0K | $96.0K | $124.0K | $150.0K | $176.0K | $201.0K | $225.0K | $249.0K | $272.0K | $294.0K | $316.0K | $337.0K | $4.0K | $4.0K | $396.0K | $415.0K | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $231M | $230M | $229M | $216M | $183M | $182M | $181M | $180M | $179M | $167M | $167M | $166M | $166M | $128M | $128M | $128M | |
| Retained Earnings | $-193M | $-183M | $-173M | $-164M | $-155M | $-148M | $-140M | $-132M | $-126M | $-121M | $-116M | $-110M | $-106M | $-101M | $-96M | $-92M | |
| AOCI | $-37.0K | $-26.0K | $50.0K | $50.0K | $-14.0K | $5.0K | $23.0K | $81.0K | $-51.0K | $-39.0K | $6.0K | $-127.0K | $-63.0K | $-29.0K | $-74.0K | $-162.0K | |
| Stockholders' Equity | $38M | $47M | $56M | $52M | $27M | $34M | $41M | $48M | $53M | $46M | $51M | $56M | $60M | $27M | $32M | $35M | |
| Liabilities + Equity | $45M | $53M | $61M | $57M | $31M | $39M | $46M | $53M | $57M | $49M | $54M | $58M | $62M | $30M | $34M | $37M | |
| Shares Outstanding | 53,925,697 | 53,883,345 | 53,742,370 | 52,077,439 | 43,072,488 | 42,859,465 | 42,818,660 | 42,766,497 | 42,692,582 | 37,963,916 | 37,958,000 | 37,953,711 | 37,949,422 | 26,464,977 | 26,443,067 | 26,443,067 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $822.0K | $1M | $1M | $771.0K | $867.0K | $589.0K | $565.0K | $443.0K | $488.0K | $456.0K | $425.0K | $380.0K | $422.0K | $411.0K | $418.0K | |
| Operating Cash Flow | $-8M | $-9M | $-8M | $-7M | $-8M | $-7M | $-6M | $-4M | $-5M | $-7M | $-4M | $-5M | $-5M | $-5M | $-3M | $-2M | |
| CapEx | $3.0K | $8.0K | $6.0K | $16.0K | $6.0K | $12.0K | $7.0K | $9.0K | $0 | $9.0K | $3.0K | $10.0K | $4.0K | $7.0K | $32.0K | $43.0K | |
| Investing Cash Flow | $8M | $-2M | $8M | $-26M | $9M | $7M | $5M | $-6M | $5M | $4M | $6M | $1M | $-28M | $3M | $5M | $2M | |
| Stock Issued | · | · | $12M | $32M | · | · | $0 | $0 | · | · | $0 | $-4.0K | · | · | $0 | $0 | |
| Financing Cash Flow | $132.0K | $417.0K | $12M | $32M | $161.0K | $91.0K | $120.0K | $123.0K | $12M | $-1.0K | $-1.0K | $-6.0K | $37M | $-1.0K | $-1.0K | $-2.0K | |
| Net Change in Cash | $261.0K | $-11M | $12M | $-783.0K | $2M | $-436.0K | $-1M | $-10M | $12M | $-2M | $2M | $-4M | $4M | $-3M | $2M | $-291.0K | |
| Free Cash Flow | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | · | · | · | $-5M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -26.5% | -21.9% | · | -15.7% | -17.4% | -17.5% | · | -11.3% | -8.6% | -13.0% | · | -9.4% | -8.8% | -14.6% | · | -7.1% | |
| ROE | -30.9% | -24.7% | · | -17.3% | -19.1% | -19.2% | · | -12.1% | -9.0% | -14.0% | · | -9.9% | -9.2% | -15.6% | · | -7.4% | |
| ROIC | -27.4% | -22.2% | · | -17.5% | -29.5% | -24.0% | · | -14.4% | -10.6% | -12.4% | · | -9.3% | -8.0% | -20.5% | · | -8.9% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 9.1 | · | 10.7 | 7.6 | 8.0 | · | 11.8 | 17.8 | 18.1 | · | 22.1 | 21.2 | 10.5 | · | 23.7 | |
| Quick Ratio | 6.6 | 9.0 | · | 10.6 | 7.3 | 7.8 | · | 11.7 | 17.6 | 17.9 | · | 21.6 | 20.8 | 10.2 | · | 23.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.71 | $0.88 | · | $0.99 | $0.63 | $0.79 | · | $1.12 | $1.25 | $1.22 | · | $1.47 | $1.57 | $1.02 | · | $1.33 | |
| Cash / Share | $0.10 | $0.09 | · | $0.06 | $0.10 | $0.06 | · | $0.10 | $0.33 | $0.06 | · | $0.06 | $0.15 | $0.08 | · | $0.10 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-38M | $-35M | · | $-32M | $-30M | $-27M | · | $-22M | $-20M | $-19M | · | $-18M | $-17M | $-15M | · | $-13M | |
| Market Cap | $380M | $365M | · | $358M | $168M | $162M | · | $179M | $126M | $105M | · | $98M | $164M | $40M | · | $33M | |
| P/B | 9.9 | 7.7 | · | 6.9 | 6.2 | 4.8 | · | 3.7 | 2.4 | 2.3 | · | 1.8 | 2.7 | 1.5 | · | 0.9 | |
| P / Tangible Book | 9.9 | 7.7 | · | 6.9 | 6.2 | 4.8 | · | 3.7 | 2.4 | 2.3 | · | 1.8 | 2.7 | 1.5 | · | 0.9 | |
| P / Cash Flow | · | -40.2 | · | · | · | -22.7 | · | · | · | -15.8 | · | · | · | -8.0 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-33M | $-24M | $-19M | $-14M | $-14M |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 11.8 | 8.3 | 19.3 | 15.6 | 29.8 |
| Quick Ratio | 11.7 | 8.2 | 19.1 | 15.5 | 29.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-29M | $-22M | $-19M | $-12M | $-12M |
Institutional owners (13F) 90 filers · $98.5M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
90
Value held
$98.5M
New positions
11
Exited positions
19
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (-10 vs prior Q) | 19 (+8 vs prior Q) | 32 (+4 vs prior Q) | 18 (-7 vs prior Q) | +725K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| COOPERMAN LEON G | $24,288,000 | 3,450,000 | 24.65% | Shares |
| BlackRock, Inc. | $15,856,086 | 2,252,285 | 16.10% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $6,296,035 | 894,115 | 6.39% | Shares |
| MILLENNIUM MANAGEMENT LLC | $5,950,975 | 845,309 | 6.04% | Shares |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | $5,923,750 | 875,000 | 6.01% | Shares |
| VANGUARD GROUP INC | $5,756,035 | 723,120 | 5.84% | Shares |
| STATE STREET CORP | $4,553,071 | 646,743 | 4.62% | Shares |
| Bleichroeder LP | $2,691,512 | 382,317 | 2.73% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,502,882 | 355,523 | 2.54% | Shares |
| OSAIC HOLDINGS, INC. | $2,380,261 | 338,107 | 2.42% | Shares |
| NORTHERN TRUST CORP | $2,305,727 | 327,518 | 2.34% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,771,764 | 251,671 | 1.80% | Shares |
| LPL Financial LLC | $1,643,840 | 233,500 | 1.67% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,460,364 | 207,438 | 1.48% | Shares |
| GOLDMAN SACHS GROUP INC | $1,183,185 | 168,066 | 1.20% | Shares |
| CITADEL ADVISORS LLC | $1,026,925 | 145,870 | 1.04% | Shares |
| Squarepoint Ops LLC | $1,022,539 | 145,247 | 1.04% | Shares |
| Bank of New York Mellon Corp | $829,449 | 117,820 | 0.84% | Shares |
| MEMBERS WEALTH LLC | $713,729 | 101,382 | 0.72% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $680,705 | 96,691 | 0.69% | Shares |
| COBALT CAPITAL MANAGEMENT, INC. | $633,600 | 90,000 | 0.64% | Shares |
| Trexquant Investment LP | $595,922 | 84,648 | 0.60% | Shares |
| MAGNOLIA CAPITAL ADVISORS LLC | $544,931 | 77,405 | 0.55% | Shares |
| Diametric Capital, LP | $539,411 | 76,621 | 0.55% | Shares |
| Blue Trust, Inc. | $486,619 | 69,122 | 0.49% | Shares |
| BANK OF AMERICA CORP /DE/ | $406,292 | 57,712 | 0.41% | Shares |
| BANK OF MONTREAL /CAN/ | $386,806 | 54,944 | 0.39% | Shares |
| Private Capital Management, LLC | $352,000 | 50,000 | 0.36% | Shares |
| Nuveen, LLC | $340,377 | 48,349 | 0.35% | Shares |
| MORGAN STANLEY | $329,993 | 46,874 | 0.33% | Shares |
| Meridian Wealth Management, LLC | $306,944 | 43,600 | 0.31% | Shares |
| Ballentine Partners, LLC | $288,725 | 41,012 | 0.29% | Shares |
| CATALYST FINANCIAL PARTNERS LLC | $270,737 | 38,457 | 0.27% | Shares |
| WELLS FARGO & COMPANY/MN | $259,973 | 36,928 | 0.26% | Shares |
| DEUTSCHE BANK AG\ | $255,714 | 36,323 | 0.26% | Shares |
| AWM Investment Company, Inc. | $253,440 | 36,000 | 0.26% | Shares |
| World Investment Advisors | $250,321 | 36,975 | 0.25% | Shares |
| HSBC HOLDINGS PLC | $244,702 | 34,224 | 0.25% | Shares |
| RHUMBLINE ADVISERS | $221,471 | 31,460 | 0.22% | Shares |
| ROYAL BANK OF CANADA | $172,000 | 24,322 | 0.17% | Shares |
| Creative Planning | $169,946 | 24,140 | 0.17% | Shares |
| UBS Group AG | $160,857 | 22,849 | 0.16% | Shares |
| MetLife Investment Management, LLC | $143,475 | 20,380 | 0.15% | Shares |
| Invesco Ltd. | $138,716 | 19,704 | 0.14% | Shares |
| Brevan Howard Capital Management LP | $126,973 | 18,036 | 0.13% | Shares |
| CITIGROUP INC | $121,594 | 17,272 | 0.12% | Shares |
| HighTower Advisors, LLC | $120,208 | 17,075 | 0.12% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $118,800 | 16,875 | 0.12% | Shares |
| Cornerstone Wealth Management, LLC | $114,400 | 16,250 | 0.12% | Shares |
| RAYMOND JAMES FINANCIAL INC | $111,169 | 15,791 | 0.11% | Shares |
Company insiders 21 insiders · 4 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Dietrich John Pauls | President & CEO | Aug. 10, 2026 A | 128,791 | 0 | 0 | $0 |
| Scott Kellen | CFO & Secretary | June 1, 2026 A | 32,290 | 0 | 0 | $0 |
| Julie Krop | Chief Medical Officer | June 1, 2026 A | · | 0 | 0 | $0 |
| David J. Wambeke | Chief Business Officer | June 1, 2025 A | 527,114 | 0 | 0 | $0 |
| Charles Pauling Semba | Director | June 1, 2026 A | 47,963 | 0 | 0 | $0 |
| James T. Parsons | Director | June 1, 2026 A | 97,949 | 0 | 0 | $0 |
| Randall Michael Giuffre | Director | June 1, 2026 A | 398,587 | 0 | 0 | $0 |
| Tanya Lewis | Director | June 1, 2026 A | · | 0 | 0 | $0 |
| Richard D. Pilnik | Director | April 7, 2025 M | 312,995 | 0 | 0 | $0 |
| Richard Jacinto II | 10% owner | July 23, 2025 P | 4,958,823 | 0 | 0 | $0 |
| Daniel J. O'Connor | · | June 1, 2026 A | · | 0 | 0 | $0 |
| Richard Kuntz | · | June 1, 2026 A | 24,210 | 0 | 0 | $0 |
| Dominic R Cundari | · | June 1, 2024 A | · | 0 | 0 | $0 |
| Masuoka K. Lorianne | · | Jan. 22, 2024 A | · | 0 | 0 | $0 |
| Julie Vanorsdel Daves | · | June 1, 2023 A | · | 0 | 0 | $0 |
| Kirsten L Gruis | · | June 1, 2023 A | · | 0 | 0 | $0 |
| Amy L. Burroughs | · | Jan. 3, 2023 A | 73,288 | 0 | 0 | $0 |
| Harry W Alcorn JR | · | Sept. 15, 2021 P | 43,582 | 0 | 0 | $0 |
| Sydney A. Gilman | · | July 28, 2021 A | · | 0 | 0 | $0 |
| Zhenyu Xiao | · | June 24, 2019 A | 7,100 | 0 | 0 | $0 |
| Todd A. Verdoorn | · | June 24, 2019 A | 2,000 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 8 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.06% | 124,465 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 38,896 SH | Aug. 19, 2026 | Daily |
| IWO · iShares Trust | 0.02% | 344,141 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 210,368 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 916,250 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 17,486 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 355,523 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,407 SH | Aug. 19, 2026 | Daily |
DMAC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 11 analysts
BUY
Median target
$13.00
+58.0%
2 18.2%
Strong Buy
8 72.7%
Buy
1 9.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-09-30Mean target $15.50 +88.3%
← Below all targets
Current price $8.23
Low$11.00
Mean$15.50
High$25.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DMAC | $428M | · | · | · | -78.7% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| GALT | $271M | -8.7 | · | · | 25.0% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 10, 2026